Martin Palin explores the implications of the supply-driven system of pharmaceuticals in Australia. Without the innovations being driven by pharmaceutical companies, there’s not a whole lot for regulators to approve or governments to buy.
Martin Palin explores the implications of the supply-driven system of pharmaceuticals in Australia. Without the innovations being driven by pharmaceutical companies, there’s not a whole lot for regulators to approve or governments to buy.
We’re always happy to talk through what might be possible for you, from a health PR brief to what a great campaign might look like.